We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 30, 2022

Finerenone in Patients With CKD and Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment

Diabetes Care


Additional Info

Diabetes Care
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Diabetes Care 2022 Aug 15;[EPub Ahead of Print], P Rossing, SD Anker, G Filippatos, B Pitt, LM Ruilope, AL Birkenfeld, JB McGill, SE Rosas, A Joseph, M Gebel, L Roberts, MF Scheerer, GL Bakris, R Agarwal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading